Search this site:

Vol. 28, No. 2
February 2005

Editorials

Another Pill For Weight Reduction

C. R. Conti, M.D., M.A.C.C. 59

Reviews

Congenital Coronary Artery Anomalies in the Adult: A New Practical Viewpoint

G. Rigatelli, M.D., FSCAI, FESC, FACC, G. Rigatelli, M.D., FSCAI, FESC 61

The Effects of Statin Therapy on Plasma Markers of Inflammation in Patients without Vascular Disease

B. Ky, M.D., and D. J. Rader, M.D. 67

Clinical Investigations

Effect of Preexisting Statin Use on Expression of C-Reactive Protein, Adhesion Molecules, Interleukin-6, and Antioxidized Low-Density Lipoprotein Antibody in Patients with Unstable Angina Undergoing Coronary Stenting

Y.-C. Doo, M.D., S.-J. Han, M.D., S.-W. Han, M.D., W.-J. Park, M.D., S.-H. Choi, M.D., G.-Y. Cho, M.D., K.-S. Hong, M.D., K.-R. Han, M.D., N.-H. Lee, M.D., D.-J. Oh, M.D., K.-H. Ryu, M.D., C.-Y. Rim, M.D., K.-H. Lee, M.D., Y. Lee, M.D. 72

The New Definition of Myocardial Infarction - Can We Use It?

S. Agewall, M.D., Ph.D., C. Löwbeer, M.D. 77

Coronary Artery Calcium by Digital Cinefluoroscopy in Patients with Pain Suggestive of an Acute Coronary Syndrome

D. Alexopoulos, M.D., FACC, FESC, C. Stathopoulos, M.D., A. Kotsaridis, M.D., J. Chiladakis, M.D., FESC, G. Hahalis, M.D., FESC 81

Cardiovascular Anomalies in Children and Young Adults with Ullrich-Turner Syndrome - The Erlangen Experience

T. M.K. Völkl, M.D., K. Degenhardt, M.D., A. Koch, M.D., D. Simm, M.D., H.G. Dörr, M.D., H. Singer, M.D. 88

Abnormal Myocardial Perfusion and Contractile Recruitment during Exercise in Type 1 Diabetic Patients

R. Scognamiglio, M.D., C. Negut, M.D., S. Vigili de Kreutzenberg, M.D., M. Palisi, M.D., A. Tiengo, M.D., A. Avogaro, M.D. 93

Images in Cardiology

A Case of Tamponade Complicating Pregnancy

E. Ansari, M.D., B. J. Karas, M.D., L. Jiang, M.D. 71

Three-Dimensional Computed Tomography Imaging of Left Atrial Anatomy for Atrial Fibrillation Ablation

J. S. Shinbane, M.D., M. J. Girsky, M.D., A. Chau, B.S., S. Mao, M.D., and M. J. Budoff, M.D. 100

Progress in Clinical Trials

ARBITER 2 (ARterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol) 101
CARP (The Coronary Artery Revascularization Prophylaxis) Trial 101
CREATE-ECLA (Clinical trial of metabolic modulation in ami tREATment Evaluation-Estudos Cardiol—gicos LatinoAmŽricaÑRiviparin) 102
ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) 102
SCD-HeFT (Cost-Effectiveness of Implantable Cardioverter Defibrillator [ICD] Therapy in the Sudden Cardiac Death in Heart Failure Trial) 103
SHIELD (SHock Inhibition Evaluation with azimiLiDe) 103

Profiles in Cardiology

Michael B. Gravanis

J. W. Hurst, M.D., MAPC 104

Continuing Medical Education

Articles in Brief A18
Calendar A24
Instructions to Authors 86L

©1997-2002 Foundation for Advances in Medicine and Science